Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project

PURPOSE: To determine whether acute kidney injury (AKI) is identified within the US Food and Drug Administration's Adverse Events and Reporting System (FDA AERS) as an adverse event resulting from bisphosphonate (BP) use in cancer therapy. METHODS: A search of the FDA AERS records from January...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Edwards, Beatrice J., Usmani, Sarah, Raisch, Dennis W., McKoy, June M., Samaras, Athena T., Belknap, Steven M., Trifilio, Steven M., Hahr, Allison, Bunta, Andrew D., Abu-Alfa, Ali, Langman, Craig B., Rosen, Steve T., West, Dennis P.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2013
נושאים:
Health Policy
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595436/
https://ncbi.nlm.nih.gov/pubmed/23814519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000486
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים